Dr. Julia Collins Motherway, MD

Dr. Motherway practices at Tustin Irvine Internal Medicine Group Inc. in Tustin, California.

Dr. Motherway's NPI, 1962544494, was assigned on February 12, 2007. Dr. Motherway graduated from Georgetown University School Of Medicine in 1994. Dr. Motherway holds California license A061483.

Dr. Motherway's primary practice is Tustin Irvine Internal Medicine Group Inc., at 15000 Kensington Park Dr, Tustin, CA 92782 in Orange County. The practice phone is (714) 838-5610.

Dr. Motherway's primary practice is Tustin Irvine Internal Medicine Group Inc. in Tustin, California. Dr. Motherway is also affiliated with Hoag Hospital Newport Beach. The medical group on file is Tustin Irvine Internal Medicine Group. Dmand AI also links Dr. Motherway to 2 more hospitals, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Motherway practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Motherway's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Motherway is board certified in internal medicine by the American Board of Internal Medicine. Dr. Motherway is licensed in California.

Dmand AI lists acid reflux, acute sinusitis, acute skin infection, adjustment disease, aneurysm, anxiety, arthritis and asthma among the conditions Dr. Motherway treats.

CMS data shows 2,032 Medicare services from Dr. Motherway across 16 procedure codes in 2024, for 302 Medicare patients. Medicare paid $165,767 for them. Every service was in an office.

CMS counts 302 Medicare patients who saw Dr. Motherway in 2024. The largest group is 75 to 84, with 127 patients. 71% of them have high cholesterol, and 60% have arthritis. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Motherway's median patient age at 72, with 75% women.

In 2024, Dr. Motherway wrote 4,458 Medicare Part D claims for 423 patients. 88% of them were for generic drugs. CMS names the drug for 3,919 of them, across 79 drugs with 11 or more claims each, at $287,012 in total drug cost. In 2023, CMS named 3,868 claims across 83 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Motherway for performance year 2024, reported individually. Dr. Motherway accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 196 general payments to Dr. Motherway from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $737.

Dmand AI lists 1 award for Dr. Motherway, most recently CMS Stage 1 2012 in 2012.

Dr. Motherway graduated from Georgetown University School Of Medicine in 1994.

Dr. Motherway is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.